Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Dolby Laboratories (NYSE:DLB) and maintained a $98 price target for the company's stock.

January 31, 2024 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel reiterates a Buy rating on Dolby Laboratories with a maintained price target of $98, indicating a positive outlook for the stock.
The reiteration of a Buy rating by a prominent analyst like Steve Frankel from Rosenblatt, along with the maintenance of a high price target, suggests a strong vote of confidence in Dolby Laboratories' stock. This could positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100